Iambic Therapeutics
iambic.ai
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Overview
Iambic Therapeutics combines machine learning with automated chemistry to discover small molecule drugs. Its NeuralPLexer models predict how proteins and candidate molecules bind. The company advances its own oncology pipeline built with those tools.
News
Upcoming To be released on October 30, 2025 October 30, 2025 2025 Promise & Reality: Decoding AI's Impact On Drug Development Learn more
Read more
Report
Upcoming To be released on September 23, 2025 September 23, 2025 2025 Enchant: A Multi-Modal Transformer Model to Break Down the Data Wall between Preclinical and Clinical Research and Development Learn more
Read more
Report
Upcoming To be released on September 22, 2025 September 22, 2025 2025 Leveraging AIML to Engineer Next-Generation HER2 Inhibitors with Enhanced Selectivity and Brain Penetrance Learn more
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Diego
United States
HQ